Insider trade

Officer sold ~$729K of INCY shares in the open market

Traded Aug 3, 2026 · Filed Aug 4, 2026

IncyteINCY

~$729K
Reported value · 6,055 sh @ $120.43: 61K
Holds after · shares reported: -1.1%
stock since the trade · S&P 500 +0.8%, $118.43 → $117.14 on Oct 1

Why it stands out

Incyte's & Chief Scientific Officer sold $729K of Incyte shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 3, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 4, 2026

Officer$500K–$1MPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$729,204

Shares × reported transaction price

Timing vs results

6 days after results of Jul 28, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $118.43 on Aug 3, 2026, 53% above its 52-week low and 9% below its high, after a 21% rise over the previous 30 trading days

52-week range $77.65 (Aug 6, 2025) to $129.93 (Jul 28, 2026), 78% of the way up, from 251 adjusted closes. 30 trading days earlier: $98.22 on Jun 18, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+0.8%	+0.3%	+0.5%
30 days	+5.8%	+0.1%	+5.8%

Past results only. Not a forecast.

Source receipt

Record ID: 0002079962-26-000013
Filed / recorded: Aug 4, 2026, 8:04 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: INCYTE CORP
Issuer CIK: 879169
Ticker: INCY
Reporting person: Patrick A Mayes
Relationship: Officer
Officer title: EVP & Chief Scientific Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Aug 3, 2026
Transaction code: S
Shares / units: 6,055
Price per share: $120.43
Acquired / disposed: Disposed (D)
Shares owned after: 61,441
Ownership form: Direct
Amendment: No

Footnotes from the filing

This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.

Around the same time

6w ago

504Shares · @ $129.72

Routine share withholding; mechanical by default.

Why it stands out Official record

Officer sold ~$1.36M of Incyte

Automatic sale7w ago

Officer sold ~$1.3M of Incyte